You are using an outdated browser. Please upgrade your browser to improve your experience.

blinatumomab

Ligand Summary
Description
a single-chain bispecific recombinant antibody from Micromet's BiTE (bispecific T-cell engager) product platform that binds both the CD19 antigen and the T-cell receptor (CD3), for the potential treatment of B-cell lymphoma
Synonyms & Links
ChEMBL: CHEMBL1742992
DrugCentral: 4915
LyCHI:  blinatumomab


Target Activities